1[1]Freeman D J,Norrio M J,et al.C-reactive protein is an inde pendent p redictor of risk for the development of diabetes in the west of scot land coronary prevention study.Diabetes,2002,51:1596-1600.
2[2]Tense P J.Von Willebrand factor,C-reactive protein and 5-year mortality in diabetic and nondiabetic subjects:the hoon study.Arterioscler Thromb Vasc Biol,1999,19:3071-3078.
4[4]Kunsch C,Medford RM.Oxidative stress as a regulator of gene expression in the vasculammat.Cire Res,1999,85(8):753-766.
5[5]Erbagel A,Tarakcioglu M,Coskum Y,et al.Mediators of inflammation in children with type ldiabetes mellitus:cytokines in type l diabetic children.Clin Biochem,2001,34:645-650.
6[6]Kaysen GA.The macroin flammat ory state in uremia:causes and potential consequences.J Am Soc Nephrol,2001,12:1549-1557.
二级参考文献9
1Rodriguez-Moran M; Guerrero-Romero F. Increased levels of C-reactive protein in non-controlled type Ⅱ diabetic subjects [J]. J Diabetes Complications, 1999, 13(4): 211-5.
2Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study [ J ]. Diabetes, 2001, 50 (10):2384-9.
3Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein. interleukin 6, and risk of developing type 2 diabetes mellitus [J ]. JAMA,2001, 18, 286(3): 327-34.
4Forouhi NG, Satter N, McKeigue PM. Relation of C-reactive protein to body distribution and feature of the metabolic syndrome in Europeans and South Asians[J]. Int J Obes Relat Metab Disord, 2001, 25(9): 1327-31.
5Moro E, Gallina P, Pais G, et al. Hypertriglyceridemia is associated with increased insulin resistance in subjects with normal glucose tolerance: evaluation in a large cohort of subjects assessed with 1999World Health Organization criteria for the classification of diabetes[J]. Metabolism, 2003, 52(5): 616-9.
6Haffner SM, Mykkanen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects[J ]. Circulation, 2000, 101: 975-80.
7Kelly CC, Lyall H, Petrie JR, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome [J]. J Clin Endocrinol Metab, 2001, 86(6): 2453-5.
8Pannacciuilli N, Cantatore FP, Minenna A, et al. C-reactive protein is independent associated with total body fat, center fat, and insulin resistance in adult women[J]. Int J Obes Relat Metab Disord, 2001, 25(10): 1416-20.
9Festa A, D'Agostino R, Howard G, et al. Chronic sub-clinical inflammation as part of the insulin-resistance syndrome: the insulin resistance atherosclerosis study (IRAS)[J ]. Circulation, 2000,102(1): 42-7.
5GALKINA E,LEY K.Leukocyte recruitment and vascular injury in diabetic nephropathy[J].J Am Soc Nephrol,2006,17(2):368-377.
6KIKUCHI Y,IKEE R,HEMMI N,et al.Fractalkine and its receptor,CX3CR1,upregulation in streptozotocin-induced diabetic kidneys[J].Nephron Exp Nephrol,2004,97(1):e17-e25.
7KIKUCHI Y,IMAKIIRE T,HYODO T,et al.Advanced glycation end-product induces fractalkine gene upregulation in normal rat glomeruli[J].Nephrol Dial Transplant,2005,20(12):2690-2696.
8ARONSON D,BARTHA P,ZINDER O,et al.Association between fasting glucose and C-reactive protein in middle-aged subjects[J].Diabet Med,2004,21(1):39-44.
9Kaysen GA. Inflammation: Cause of vascular disease and malnu- trition in dialysis patients . Semin Nephrol, 2004, 24 ( 5 ) : 431- 436.
10Afzal N, Abbas S, Ahmed A, et al. Effect of hepatitis C virus on C- re-active protein and interleukin-6 in hemodialysis patients. Iran J Kidney Dis,2011,5(3) : 182-186.
